A non-profit organization that encourages investigation of innovative cancer treatment and detection for difficult-to-treat and understudied cancers, supporting scientific and medical research programs aimed at increasing knowledge relating to cancer care and prevention.

The Hope Funds for Cancer Research

MISSION:
The mission of the Hope Funds for Cancer Research is to encourage investigation of innovative cancer treatment and detection for the most difficult-to-treat and understudied cancers. The Hope Funds for Cancer Research supports scientific and medical research programs aimed at increasing knowledge relating to both cancer care and prevention. We support programs we believe have the highest probability of success in addressing unmet medical needs, which we will determine by rigorous scientific and economic analysis.

SCIENTIFIC ADVISORY COUNCIL:
Kenneth C. Anderson, MD; Imre Bartos, Ph.D; Lewis Cantley, PhD; William Cho, PhD; Don Cleveland, PhD; George Demetri, MD; Gina DeNicola, PhD; Wolfram Goessling, MD, PhD; William C. Hahn, MD, PhD; Kyle Hoehn, PhD; Robert Johnson, MD PhD; Carla Kim PhD; Bluma Lesch, MD, PhD; Scott Power PhD; John Quackenbush, PhD; Joshua Rabinowitz, MD, PhD; Thomas Reynolds, MD; Joan M. Robbins, PhD; Taksiha Shimokawa, PhD; Frank J. Slack, PhD, Joan A. Steitz, PhD; Sohail Tavazoie, PhD; James Watson, PhD; Robert A. Weinberg PhD; Professor Bryan R.G. Williams, PhD; Monte Winslow, PhD; Richard Young, PhD.

BOARD OF TRUSTEES:
Leah Rush Cann, Lewis C. Cantley, Ph.D., Katherine Dean, Samuel Gillson, Dan Gold, PhD, Jessica Guertin, Elizabeth Griffin, Adrian Hobden, PhD, Charles Holmes, Eugene Kennedy, MD, Bluma Lesch, MD, PhD, Robert Johnson, MD, PhD, Malcolm A.S. Moore, DPhil, Andrew Mullen, PhD, Steven A. Navarro, JD, John E. Parks, Andrew Robertson, David J. Straus, MD, J. Gregory Van Schaack, John Archer Wells, Bryan R.G. Williams; Life Trustees: Robert Bazell, Patricia F. Bilden, MD, Antonio J. Grillo-Lopez, MD, Gary Jobson, Jonathan Lewis, MD, PhD, Paul D. Maxwell, O. Lee Tawes III

Hope Funds for Cancer Research

Attending a Hope Funds Award of Excellence Gala, as anyone who has had the opportunity to do, is a special evening. Often set in a Newport or New York historic landmark, the guests have the opportunity to hear directly from the world renowned figures who are receiving the awards. To help share the wisdom of these towering figures (including many Nobel Prizes winners and many who went on to receive the Nobel Prize after receiving the Hope Funds Award) the Hope Funds for Cancer Research has created a short documentary called "How to Win a Nobel Prize" in partnership with producer and narrator Gary Jobson. Here is the one-minute trailer for the movie, coming to a film festival, club or venue near you: https://lnkd.in/eaZGQdRc
Eventually the whole film will eventually be loaded to our YouTube channel so please subscribe to both the HFCR LinkedIn and YouTube pages! #CancerResearch #HopeFunds #NobelPrize

The Hope Funds for Cancer Research is pleased to share the news that alumnus Mat Legut's company OverT Bio has received $16 Million in start-up funding for their groundbreaking research efforts. We wish Dr. Legut and his team the very best of success. https://lnkd.in/gApWHgnx
#HopeFunds #OverTBio #BiotechResearch #EndCancer

#PressRelease #HopeFunds #2024Awardees #AwardOfExcellence

For 17 years, A4 Architecture has been responsible for arranging the design and layout for countless events for the Hope Funds for Cancer Research, including 5 in just the past week. Here is a short article describing their long-time involvement with this organization that has dedicated itself to assisting us in funding the most outstanding post-doctoral investigators in the world studying hard to treat and underfunded cancer research: https://lnkd.in/ePbt22tD 
Thank you for reading, liking, commenting and sharing this post and following the Hope Funds for Cancer Research if you care about the fight to conquer this insidious disease!
#HopeFunds #CancerResearch #FundScience #NewportRI #A4architecture #ArchitecturalSettings

Linda G. Gordon, 83 of Newport, RI, died on May 29, 2024, after a short battle with acute myeloid leukemia (AML). She was the wife of the late Honorable David S. Gordon, former Newport mayor.

Linda and David moved to Newport from New York City about 40 years ago and immediately embraced the city and the community. Linda was a very private person but relished the dear friendships she had cultivated over the years. A natural artist, she took watercolor classes when she first moved to Newport and painted the most wonderful scenes of various landscapes from throughout the island. 

Linda will be remembered for her kindness, how graciously she lived, her sense of humor, her elegance, and for all she did for the betterment of Newport, including her involvement with numerous cultural and educational activities. A passionate advocate for the City of Newport, she spearheaded a project to restore Newport’s public statues and successfully co-chaired the Stanford White Casino Theatre Restoration. Most recently she served on the Alfred G. Vanderbilt Memorial restoration committee and then the newly formed Public Sculpture Commission. She also was recently a board member of Hope Funds for Cancer Research and served on its Development Committee.

Linda was a member many other committees and boards including the Exhibitions and Collection Committee and the Honorary Advisory Council of the Newport Art Museum. For a number of years, she was on the Doris Duke Historic Preservation Awards Celebration Committee of the Newport Restoration Foundation. She formerly was on the board of the old Rhode Island Shakespeare Theater and a member of the Advisory Commission for the Common Burying Ground.

Prior to moving to Newport, she worked in public relations at The NY Museum of Modern Art for 16 years, and was director of public relations at the Whitney Museum of American Art in New York from 1978 to 1987.
Born in 1940 in Rochester, NY, she was the daughter of the late Betty Hart Bachmann and of Lawrence P. Bachmann of Oxfordshire, England, and of the late Leon H. Goldsmith, Jr. of Rochester. She was the granddaughter of Alfred Hart, a well-respected Rochester philanthropist and founder of the popular Hart’s Food Stores. She was the sister of the late Hart A. Goldsmith of Pittsford, NY. She leaves a daughter, Jessica Gordon Ryan, of Southport, CT, and three grandchildren, Rebecca Hart Ryan, Christopher James Ryan, and Alexander Gordon Ryan who miss her terribly. She attended Skidmore College and l’Ecole du Louvre, Paris.

There will be no funeral or other public event. In lieu of flowers, donations may be made to Hope Funds for Cancer Research, 174 Bellevue Avenue, Suite 208, Newport RI 02840. She will be deeply missed by her family friends and colleagues.

Metric
Company Name	The Hope Funds for Cancer Research
Symbol
MSH ID	ORG:HOPE-FUNDS
Market	PRIVATE
Sector	Healthcare & Health Services
Industry	Cancer Research
Country	US
Stage
Employee Count	20
Website	hope-funds.org
LinkedIn	hope-funds-for-cancer-research
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

HOPE

ORG:HOPE-FUNDS

The Hope Funds for Cancer Research

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue